{"transactions":[{"id":730383,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-22T20:28:48.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":49579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 17, 2027, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":49579,"derivative":{"exercise_price":1.13,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":49579},"source":{"system":"sec-edgar","filing":"0000905148-26-003055","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000090514826003055/form4.xml","form_type":"4"}},{"id":730382,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T20:28:48.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":30421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 17, 2027, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":70314,"source":{"system":"sec-edgar","filing":"0000905148-26-003055","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000090514826003055/form4.xml","form_type":"4"}},{"id":739879,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T20:35:46.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire option award shall vest on the earlier of:  (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on the applicable vesting date."}],"balance_after":22000,"derivative":{"exercise_price":15.48,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001771213-26-000004","document":"form4-06122026_080642.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000177121326000004/form4-06122026_080642.xml","form_type":"4"}},{"id":747947,"issuer":{"id":4678,"kind":"organization","name":"LB PHARMACEUTICALS INC","symbol":"LBRX"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T21:25:17.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying the option vest on the earlier of (i) June 3, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":10000,"derivative":{"exercise_price":27.95,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001771213-26-000002","document":"form4-06052026_090613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691082/000177121326000002/form4-06052026_090613.xml","form_type":"4"}},{"id":934335,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-01-21T21:30:03.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":40400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 12 equal monthly installments beginning on February 20, 2026."}],"balance_after":40400,"derivative":{"exercise_price":1.32,"expiration_date":"2036-01-19","underlying":"Common Stock","underlying_shares":40400},"source":{"system":"sec-edgar","filing":"0001193125-26-018021","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526018021/ownership.xml","form_type":"4"}},{"id":1041619,"issuer":{"id":4678,"kind":"organization","name":"LB PHARMACEUTICALS INC","symbol":"LBRX"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-12T22:25:23.000Z","date":"2025-09-10","kind":"grant","planned":false,"acquired":true,"shares":22449,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award shall vest in three (3) equal annual installments on September 10, 2026, September 10, 2027 and September 10, 2028, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":22449,"derivative":{"exercise_price":15,"expiration_date":"2035-09-09","underlying":"Common Stock","underlying_shares":22449},"source":{"system":"sec-edgar","filing":"0001415889-25-024452","document":"form4-09122025_060919.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691082/000141588925024452/form4-09122025_060919.xml","form_type":"4"}},{"id":1054423,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-27T21:12:01.000Z","date":"2025-06-25","kind":"sale","planned":true,"acquired":false,"shares":10684,"price":2.0945,"value":22377.638,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.07 to $2.1212, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":39893,"source":{"system":"sec-edgar","filing":"0000905148-25-003155","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000090514825003155/form4.xml","form_type":"4"}},{"id":1103602,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-23T22:43:30.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":50790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 18, 2026, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":50790,"derivative":{"exercise_price":2.11,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":50790},"source":{"system":"sec-edgar","filing":"0000905148-25-002234","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000090514825002234/form4.xml","form_type":"4"}},{"id":1103601,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-23T22:43:30.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":29210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 18, 2026, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":50577,"source":{"system":"sec-edgar","filing":"0000905148-25-002234","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000090514825002234/form4.xml","form_type":"4"}},{"id":1117969,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-09T20:47:25.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire option award shall vest on the earlier of:  (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on the applicable vesting date."}],"balance_after":22000,"derivative":{"exercise_price":4.44,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001415889-25-016296","document":"form4-06092025_080617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000141588925016296/form4-06092025_080617.xml","form_type":"4"}},{"id":1215112,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-10T20:11:28.000Z","date":"2024-09-27","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":18,"value":54000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were purchased through a directed share program in connection with the Issuer's initial public offering."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001415889-25-007506","document":"form4a-03102025_080325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000141588925007506/form4a-03102025_080325.xml","form_type":"4/A","original_submission_date":"2024-09-27"}},{"id":1296461,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-23T23:32:49.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":40400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 12 equal monthly installments beginning on February 21, 2025."}],"balance_after":40400,"derivative":{"exercise_price":1.65,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":40400},"source":{"system":"sec-edgar","filing":"0001415889-25-001983","document":"form4-01232025_110145.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588925001983/form4-01232025_110145.xml","form_type":"4"}},{"id":1343122,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-04T21:17:28.000Z","date":"2024-12-02","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":1.5468,"value":46404.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.515 to $1.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":33000,"source":{"system":"sec-edgar","filing":"0001415889-24-028247","document":"form4-12042024_091224.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924028247/form4-12042024_091224.xml","form_type":"4"}},{"id":1398470,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-27T20:21:15.000Z","date":"2024-04-17","kind":"grant","planned":false,"acquired":true,"shares":28497,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"This option award represents an equity security previously reported on the reporting person's Form 3, which was acquired through an exempt transaction with the Issuer prior to the Issuer registering a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended. It is reported herein as a transaction pursuant to Rule 16a-2(a)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested or vests as to 1/36th of the total award monthly, with the first tranche vesting on May 17, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":28497,"derivative":{"exercise_price":8.39,"expiration_date":"2034-04-16","underlying":"Common Stock","underlying_shares":28497},"source":{"system":"sec-edgar","filing":"0001415889-24-024043","document":"form4-09272024_080911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000141588924024043/form4-09272024_080911.xml","form_type":"4"}},{"id":1398469,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-27T20:21:15.000Z","date":"2024-09-25","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire option award shall vest on the earlier of:  (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":18,"expiration_date":"2034-09-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-24-024043","document":"form4-09272024_080911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000141588924024043/form4-09272024_080911.xml","form_type":"4"}},{"id":1479176,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T20:49:42.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":20200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 12 equal monthly installments on the 13th day of the month, or if earlier, the day immediately before the day of the next annual meeting of stockholders."}],"balance_after":20200,"derivative":{"exercise_price":8.44,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":20200},"source":{"system":"sec-edgar","filing":"0001415889-24-016955","document":"form4-06142024_080638.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924016955/form4-06142024_080638.xml","form_type":"4"}},{"id":1480423,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-13T21:38:12.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":40701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":40701,"derivative":{"exercise_price":4.68,"expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":40701},"source":{"system":"sec-edgar","filing":"0001415889-24-016713","document":"form4-06132024_090609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924016713/form4-06132024_090609.xml","form_type":"4"}},{"id":1480422,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-13T21:38:12.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":21367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":21367,"source":{"system":"sec-edgar","filing":"0001415889-24-016713","document":"form4-06132024_090609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000141588924016713/form4-06132024_090609.xml","form_type":"4"}},{"id":1845051,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T21:31:32.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 22, 2024, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":4.57,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-23-039471","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000120919123039471/doc4.xml","form_type":"4"}},{"id":1846615,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-22T20:43:16.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":20200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 12 equal monthly installments on the 20th day of the month, or if earlier, the day immediately before the day of the next annual meeting of stockholders."}],"balance_after":20200,"derivative":{"exercise_price":8.14,"expiration_date":"2033-06-19","underlying":"Common Stock","underlying_shares":20200},"source":{"system":"sec-edgar","filing":"0001209191-23-039096","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919123039096/doc4.xml","form_type":"4"}},{"id":1942834,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-21T20:45:31.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. 23,333 of the shares underlying this option vested on March 20, 2023 and the remaining 16,667 shares will vest in 15 equal monthly installments thereafter, beginning on April 14, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":4.19,"expiration_date":"2033-03-19","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-020293","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000120919123020293/doc4.xml","form_type":"4"}},{"id":2209769,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-08T20:03:34.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":26900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 29, 2023, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":26900,"derivative":{"exercise_price":4.82,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":26900},"source":{"system":"sec-edgar","filing":"0001209191-22-041607","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000120919122041607/doc4.xml","form_type":"4"}},{"id":2230118,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T00:23:08.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":12004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 12 equal monthly installments on the same day of the month as the grant date, or if earlier, the day immediately before the day of the next annual meeting of stockholders."}],"balance_after":12004,"derivative":{"exercise_price":6.67,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":12004},"source":{"system":"sec-edgar","filing":"0001209191-22-037643","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919122037643/doc4.xml","form_type":"4"}},{"id":2606720,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-11T21:15:05.000Z","date":"2021-08-09","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vest on August 9, 2022 and the remaining shares underlying the option vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":16.63,"expiration_date":"2031-08-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-050936","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287098/000120919121050936/doc4.xml","form_type":"4"}},{"id":2668641,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-15T22:50:13.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":12004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 12 equal monthly installments on the same day of the month as the grant date, or if earlier, the day immediately before the day of the next annual meeting of stockholders."}],"balance_after":12004,"derivative":{"exercise_price":59.66,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":12004},"source":{"system":"sec-edgar","filing":"0001209191-21-040725","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000120919121040725/doc4.xml","form_type":"4"}},{"id":3078889,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-22T00:03:15.000Z","date":"2020-07-21","kind":"purchase","acquired":true,"shares":3000,"price":19,"value":57000.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0000899243-20-019912","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000089924320019912/doc4.xml","form_type":"4"}},{"id":3099580,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-25T17:45:04.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of June 23, 2021 or the 2021 annual meeting of stockholders, subject to (1) accelerated vesting upon a change of control and (2) the Reporting Person's continued service with the Issuer on the vesting date."}],"balance_after":30000,"derivative":{"exercise_price":25.64,"expiration_date":"2030-06-22","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-20-038959","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501756/000120919120038959/doc4.xml","form_type":"4"}},{"id":3178895,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2020-04-09T16:10:44.000Z","date":"2020-04-08","kind":"disposition_to_issuer","acquired":false,"shares":42750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person resigned her positions as President, Chief Executive Officer and member of the Board of Directors of Aravive, Inc. on April 8, 2020, resulting in the forfeiture of 42,750 shares of common stock issuable upon the vesting of certain restricted stock units previously granted on January 9, 2020."}],"balance_after":14250,"source":{"system":"sec-edgar","filing":"0000899243-20-010591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513818/000089924320010591/doc4.xml","form_type":"4"}},{"id":3314342,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Options","published_at":"2020-01-09T19:20:19.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":143000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The stock option to purchase 143,000 shares of Common Stock vests as follows: 25% of the shares vest on the one year anniversary of the date of grant and the remaining 75% of the shares vest in equal monthly installments over the next 36 months, subject to the reporting person's continued service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option to purchase 143,000 shares of Common Stock vests as follows: 25% of the shares vest on the one year anniversary of the date of grant and the remaining 75% of the shares vest in equal monthly installments over the next 36 months, subject to the reporting person's continued service to the Company."}],"balance_after":143000,"derivative":{"exercise_price":13.77,"exercise_date":"2021-01-09","expiration_date":"2030-01-08","underlying":"Common stock","underlying_shares":143000},"source":{"system":"sec-edgar","filing":"0000899243-20-000907","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1513818/000089924320000907/doc4.xml","form_type":"4"}},{"id":3314341,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-01-09T19:20:19.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":57000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of common stock (\"Common Stock\") of Aravive, Inc. (the \"Company\"). The RSUs vest as follows: 25% of the shares vest on each of January 9, 2021, January 9, 2022 January 9, 2023 and January 9, 2024, subject to the reporting person's continued service to the Company."}],"balance_after":57000,"source":{"system":"sec-edgar","filing":"0000899243-20-000907","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513818/000089924320000907/doc4.xml","form_type":"4"}},{"id":3435825,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-16T16:15:19.000Z","date":"2019-08-15","kind":"grant","acquired":true,"shares":33750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of (a) the 2020 annual meeting of stockholders and (b) July 31, 2020.  The options were issued in connection with an amendment to the company's non-employee director compensation policy, such that the director's total annual option grants correspond to the amended policy."}],"balance_after":45000,"derivative":{"exercise_price":13.41,"expiration_date":"2029-07-30","underlying":"Common Stock","underlying_shares":33750},"source":{"system":"sec-edgar","filing":"0001209191-19-046306","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501756/000120919119046306/doc4.xml","form_type":"4"}},{"id":3448781,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T16:21:56.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of (a) the 2020 annual meeting of stockholders and (b) July 31, 2020."}],"balance_after":11250,"derivative":{"exercise_price":13.41,"expiration_date":"2029-07-30","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001209191-19-044245","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501756/000120919119044245/doc4.xml","form_type":"4"}},{"id":3539434,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-03T16:38:32.000Z","date":"2019-05-01","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the total number of shares subject to the option vest and become exercisable on each anniversary of May 1, 2019 (the \"Vesting Commencement Date\"), such that all of the shares subject to the option shall become vested and exercisable as of the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":70000,"derivative":{"exercise_price":6.48,"expiration_date":"2029-04-30","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-19-027395","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501756/000120919119027395/doc4.xml","form_type":"4"}},{"id":3579881,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-25T22:54:24.000Z","date":"2019-03-25","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable in 48 equal monthly installments after March 25, 2019, subject to the Reporting Person's continued service to the Company."}],"balance_after":400000,"derivative":{"exercise_price":11.23,"expiration_date":"2029-03-24","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001209191-19-021233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120919119021233/doc4.xml","form_type":"4"}}]}